Mutations in the FGF14 gene are not a major cause of spinocerebellar ataxia in Caucasians
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Spinocerebellar ataxias (SCAs) are heterogeneous dominantly inherited neurodegenerative disorders, clinically characterized by variable degrees of cerebellar and brainstem degeneration and dysfunction. Symptoms appear during the third or fourth decade: progressive cerebellar ataxia variably associated with ophthalmoplegia, pyramidal and extrapyramidal signs, deep sensory loss, amyotrophy, and dementia. At least 23 loci have been implicated, and nucleotide repeat expansions in nine different genes have been identified.1,2⇓ Recently, point mutations in the FGF14 and PRKCG/SCA14 genes were detected in some families, but their relative frequencies are unknown.3,4⇓
FGF14 is a member of the fibroblast growth factor protein family that is …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Articles
Ataxia with oculomotor apraxia type 2A clinical, pathologic, and genetic studyC. Criscuolo, L. Chessa, S. Di Giandomenico et al.Neurology, April 24, 2006 -
Article
Serum FGF21 levels in adult m.3243A>G carriersClinical implicationsSaskia Koene, Paul de Laat, Doorlène H. van Tienoven et al.Neurology, June 06, 2014 -
Article
FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disordersJenni M. Lehtonen, Saara Forsström, Emanuela Bottani et al.Neurology, October 28, 2016 -
Articles
The role of ataxin 10 in the pathogenesis of spinocerebellar ataxia type 10M. Wakamiya, T. Matsuura, Y. Liu et al.Neurology, August 21, 2006